Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials-Reference-Cited by-同舟云学术

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Published:2008-10 Issue:9647 Volume:372 Page:1394-1402
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chaturvedi Nish,Porta Massimo,Klein Ronald,Orchard Trevor,Fuller John,Parving Hans Henrik,Bilous Rudy,Sjølie Anne Katrin

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study;Luckie;Diabet Med,2007

2. The Diabetes Control and Complications Trial Research Group: the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;N Engl J Med,1993

3. Quality of diabetes care in US academic medical centers: low rates of medical regimen change;Grant;Diabetes Care,2005

4. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen);Prevost;Diabetes Metab,2005

5. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control;Zhang;Diabetes Care,2001

Cited by 400 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment;Ophthalmology Science;2024-07

2. The role of microglia in the development of diabetic retinopathy;npj Metabolic Health and Disease;2024-06-03

3. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

4. Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review;Biomedicines;2024-03-27

5. Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review;Journal of Biological Engineering;2024-02-22